Back
BioXcel Therapeutics Stock Price Chart
Sponsored
How He Bagged One Of The Top Trading Records
Click to see this exclusive sit-down interview
Sell
33
BTAI
BioXcel Therapeutics
Last Price:
18.31
Seasonality Move:
46.06%
7 Day Trial
ALL ACCESS PASS
$
7
Sponsored
Is it possible to have a crash proof portfolio?
See important Reg A disclosures: Masterworks.com/cd- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing buying pressure, which is a positive indicator for future bullish movement.
BioXcel Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.87 | Sell |
| 20-day SMA: | 23.98 | Sell |
| 50-day SMA: | 28.08 | Sell |
| 200-day SMA: | 18.1 | Buy |
| 8-day EMA: | 19.38 | Sell |
| 20-day EMA: | 22.64 | Sell |
| 50-day EMA: | 24.84 | Sell |
| 200-day EMA: | 21.03 | Sell |
BioXcel Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.08 | Sell |
| Relative Strength Index (14 RSI): | 26.92 | Sell |
| Chaikin Money Flow: | 503402 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.83 - 30.77) | Sell |
| Bollinger Bands (100): | (16.07 - 29.65) | Sell |
BioXcel Therapeutics Technical Analysis
| Mar-13 | Mar-14 | Mar-15 | Mar-16 | Mar-17 | Mar-20 | Mar-21 | Mar-22 | Mar-23 | Mar-24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioXcel Therapeutics Stock
Is BioXcel Therapeutics Stock a Buy?
- BioXcel Therapeutics share price is 18.32 while BTAI 8-day simple moving average is 18.87, which is a Sell signal.
- The stock price of BTAI is 18.32 while BioXcel Therapeutics 20-day SMA is 23.98, which makes it a Sell.
- BioXcel Therapeutics 50-day simple moving average is 28.08 while BTAI share price is 18.32, making it a Sell technically.
- BTAI stock price is 18.32 and BioXcel Therapeutics 200-day simple moving average is 18.10, creating a Buy signal.
BTAI Technical Analysis vs Fundamental Analysis
Sell
33
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy or a Sell?
-
BioXcel Therapeutics stock is rated a Sell
The current BioXcel Therapeutics [BTAI] share price is $18.32. The Score for BTAI is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
BioXcel Therapeutics Stock Info
Market Cap:
531.45M
Price in USD:
18.32
Share Volume:
586.67K
BioXcel Therapeutics 52-Week Range
52-Week High:
34.13
52-Week Low:
8.80
Sell
33
BioXcel Therapeutics (BTAI)
is a Sell
BioXcel Therapeutics Share Price Forecast
-
What is the BioXcel Therapeutics stock price today?
The BioXcel Therapeutics stock price is 18.32 USD today. -
Will BTAI stock go up or go down?
BioXcel Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is BioXcel Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioXcel Therapeutics is overvalued.
Is BioXcel Therapeutics Stock a Buy?
- BioXcel Therapeutics share price is 18.32 while BTAI 8-day exponential moving average is 19.38, which is a Sell signal.
- The stock price of BTAI is 18.32 while BioXcel Therapeutics 20-day EMA is 22.64, which makes it a Sell.
- BioXcel Therapeutics 50-day exponential moving average is 24.84 while BTAI share price is 18.32, making it a Sell technically.
- BTAI stock price is 18.32 and BioXcel Therapeutics 200-day simple moving average is 21.03, creating a Sell signal.
Fundamental Analysis of BioXcel Therapeutics
Is BioXcel Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.17 per share, and an increase next year of $1.92 per share.
Technical Analysis of BioXcel Therapeutics
Should I short BioXcel Therapeutics stock?
- BTAI Moving Average Covergence Divergence (MACD) indicator is -3.08, suggesting BioXcel Therapeutics is a Sell
- BioXcel Therapeutics Relative Strength Index (RSI) is 26.92, which suggest BioXcel Therapeutics is oversold
- The Bollinger Bands (25) for BioXcel Therapeutics is (19.83 - 30.77), which suggest BioXcel Therapeutics is a Sell
- The Bollinger Bands (100) for BioXcel Therapeutics is (16.07 - 29.65), which suggest BioXcel Therapeutics is a Sell
* BioXcel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.